{
  "title": "Noubar Afeyan",
  "itunes:title": "Noubar Afeyan",
  "description": "<p>Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "c7df5a48-0117-11ec-a888-1ff55f260d60",
  "omny:clipId": "0aa02fd0-1d56-42d2-b539-ae3c00060084",
  "pubDate": "Thu, 19 Aug 2021 18:08:51 +0000",
  "itunes:duration": 1362,
  "enclosure": "",
  "link": "https://omny.fm/shows/the-david-rubenstein-show/noubar-afeyan"
}